Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares and Total Voting Rights

8 Oct 2018 12:46

RNS Number : 3081D
Ideagen PLC
08 October 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Ideagen PLC

("Ideagen," the "Company" or the "Group'')

Issue of shares under the Share Incentive Plan and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces the allotment of 290,739 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the annual award of shares to eligible employees (the "Free Shares") and the further allotment of 4,168 Ordinary Shares following the monthly purchase of Ordinary Shares by a number of employees, both under the Company's Share Incentive Plan ("SIP").

Under the terms of the SIP, the Company makes an annual award of Free Shares to all eligible employees subject to the achievement of a profit target set by the Board for a particular year. The profit target was achieved in respect of the year ended 30 April 2018 and the Company has agreed to award new Ordinary Shares to the value of £2,000 to all eligible employees based on the closing mid-market price on 21 September 2018 (the "Award"). In order to obtain the full tax benefits of the SIP, members of staff will need to remain as employees of the Group for 5 years from the date of the Award.

Accordingly the Company has allotted a total of 294,907 Ordinary Shares to be held in trust for the benefit of employees.

As part of the Award, 1,201 new Ordinary Shares were allotted to each of the executive directors of the Company; David Hornsby, Ben Dorks, Graeme Spenceley and Barnaby Kent, who now have the following interests in the share capital of the company.

Executive Director

Previous shareholding

New shareholding

% of enlarged issued share capital held

David Hornsby

8,648,856

8,650,057

3.9%

Ben Dorks

1,999,323

2,000,524

0.9%

Graeme Spenceley

827,043

828,244

0.4%

Barnaby Kent

2,276,983

2,278,184

1.0%

Application has been made for the total of 294,907 new Ordinary Shares issued pursuant to the above allotments, which will rank pari passu with existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8:00am on 12 October 2018.

Following Admission, the total issued share capital of the Company will consist of 219,219,425 Ordinary Shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive Officer

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

Alice Lane (ECM)

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit, Pentana Performance and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 3,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Hornsby

2.

Reason for the Notification

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Award of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,201

d)

Aggregated information:

· Aggregated volume

· Price

 

1,201 ordinary shares of 1p each awarded

e)

Date of the transaction

08 October 2018

f)

Place of the transaction

Off market transaction

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graeme Spenceley

2.

Reason for the Notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Award of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,201

d)

Aggregated information:

· Aggregated volume

· Price

 

1,201 ordinary shares of 1p each awarded

e)

Date of the transaction

08 October 2018

f)

Place of the transaction

Off market transaction

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Dorks

2.

Reason for the Notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Award of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,201

d)

Aggregated information:

· Aggregated volume

· Price

 

1,201 ordinary shares of 1p each awarded

e)

Date of the transaction

08 October 2018

f)

Place of the transaction

Off market transaction

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Barnaby Kent

2.

Reason for the Notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Award of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,201

d)

Aggregated information:

· Aggregated volume

· Price

 

1,201 ordinary shares of 1p each awarded

e)

Date of the transaction

08 October 2018

f)

Place of the transaction

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMPBBTMBIMBIP
Date   Source Headline
10th Aug 201711:45 amRNSDirector Dealing
28th Jul 20174:19 pmRNSDirector Dealing
18th Jul 20177:00 amRNSFinal Results
12th Jun 20178:45 amRNSHolding(s) in Company
18th May 20173:19 pmRNSExercise of Options and Total Voting Rights
17th May 20177:00 amRNSPre-Close Trading Update
11th May 20172:21 pmRNSHolding(s) in Company
31st Mar 20171:10 pmRNSDirector/PDMR Shareholding
30th Mar 201711:48 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSNew Aviation SaaS contracts worth £1.8m
28th Mar 20179:16 amRNSHolding(s) in Company
27th Mar 20176:05 pmRNSHolding(s) in Company
23rd Mar 201710:49 amRNSDirectors' Dealing & Total Voting Rights
23rd Mar 20177:00 amRNSAcquisition and Placing to raise £10m
1st Mar 201711:47 amRNSExercise of Options and Total Voting Rights
1st Mar 20177:00 amRNSHolding(s) in Company
24th Feb 20172:28 pmRNSExercise of Options and Total Voting Rights
24th Feb 201712:20 pmRNSHolding(s) in Company
21st Feb 20177:00 amRNSExercise of Options and Total Voting Rights
1st Feb 201711:44 amRNSHolding(s) in Company
26th Jan 20178:29 amRNSDividend Timetable
24th Jan 20177:01 amRNSDirectorate Changes
24th Jan 20177:00 amRNSInterim Results
9th Dec 20167:00 amRNSAcquisition of IPI Solutions Ltd
7th Dec 20162:14 pmRNSHolding(s) in Company
28th Nov 20164:55 pmRNSHolding(s) in Company
24th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 201611:37 amRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Update
2nd Nov 20167:00 amRNSExercise of Options and Total Voting Rights
28th Oct 20161:26 pmRNSResult of AGM
13th Oct 20167:00 amRNSNew Contract Wins worth £1.2m
11th Oct 20167:00 amRNSExercise of Options and Total Voting Rights
6th Oct 20167:00 amRNSNotice of AGM
6th Sep 20167:00 amRNSAcquisition of Logen Ltd.
1st Sep 20167:00 amRNSExercise of Options and Total Voting Rights
12th Aug 20167:00 amRNSExercise of Options and Total Voting Rights
8th Aug 20167:00 amRNSAcquisition of Covalent Software Ltd
29th Jul 20167:00 amRNSExercise of Options and Total Voting Rights
19th Jul 20163:28 pmRNSDividend Timetable
19th Jul 20167:00 amRNSFinal Results
12th Jul 20167:00 amRNSNotice of Results
5th Jul 20167:00 amRNSHolding(s) in Company
29th Jun 20161:56 pmRNSHolding(s) in Company
18th May 20167:00 amRNSPre-Close Trading Update
5th May 20167:00 amRNSExercise of Options and Total Voting Rights
29th Apr 20167:00 amRNSNew contract wins in life science sector
29th Mar 20167:00 amRNSExercise of Options and Total Voting Rights
18th Mar 20167:00 amRNSRe £4.9m Contract and Trading Update
29th Jan 20168:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.